Thousands of bottles of duloxetine have been recalled after testing found a potentially cancer-causing impurity above federal safety limits. The voluntary drug recall, described in a notice from the U.S. Food and Drug Administration, involves pills made by Towa Pharmaceutical and distributed by Breckenridge Pharmaceutical Inc.
The move matters now because duloxetine is a prescription medicine widely used to treat depression and anxiety, and the FDA has warned that nitrosamine impurities may increase the risk of cancer when people are exposed to them above acceptable levels and over long periods of time. In this case, the impurity was identified as N-nitroso-duloxetine, a nitrosamine compound that exceeded the agency's recommended limit.
The agency drew a sharp line between risk and proof. It said people exposed to these impurities at or below the acceptable daily intake limit are not expected to have an increased risk of cancer, and it also said there is no specific evidence linking N-nitroso-duloxetine directly to cancer. Still, the product was classified as a Class II recall, a category the FDA uses when use of or exposure to a product may cause temporary or medically reversible adverse health consequences or when the probability of serious harm is remote.
That gap is what makes the recall harder to read than a simple contamination notice. The impurity is above the FDA's recommended limit, but the agency is not saying the recalled duloxetine is known to cause cancer in patients who took it. Instead, the concern is exposure over time, which is why nitrosamine issues keep drawing scrutiny even when the health evidence is indirect.
What remains unclear from the notice is which specific bottle sizes or lot numbers are covered, so patients cannot yet match a bottle in hand to the recall from the information provided here alone. For now, the clearest answer is that thousands of bottles are out of the supply chain because their impurity level crossed the federal line, and the FDA has already placed the recall in the category reserved for products that are unlikely to cause serious harm but still cannot be ignored.
